Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes

Annals of Surgical Oncology

Volumn 5, Issue 2, 1998, Pages 119-125

  Joseph, Emmanuella ^a   Brobeil, Andrea ^a   Glass, Frank ^a   Glass, Jillian ^a   Messina, Jane ^a   DeConti, Ronald ^a   Cruse, C Wayne ^a   Rapaport, David P ^a   Berman, Claudia ^a   Fenske, Neil ^a   Reintgen, Douglas S ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Lymph node dissection; Malignant melanoma; Sentinel lymph node

Indexed keywords

PROTEIN S 100;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CHILD; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHILD; EXTREMITIES; FEMALE; FOLLOW-UP STUDIES; GAMMA CAMERAS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; ROSANILINE DYES; S100 PROTEINS; SKIN NEOPLASMS; TECHNETIUM TC 99M SULFUR COLLOID; THORACIC NEOPLASMS;

EID: 0032431612     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303844     Document Type: Article

References (16)

1. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994;6:759-67.
2. Thompson JF, McCarthy WH, Bosch CMJ, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995;5:255-60.
3. Krag DN, Meijer SJ, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995;130:654-8.
4. Balch CM. The role of elective lymph node dissection in melanoma: rationale, results, and controversies. J Clin Oncol 1988;6: 163-72.
5. Balch CM, Soong S-J, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996;3:255-66.
6. Morton DL, Wen DR, Wong JH. et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
7. Norman J, Cruse CW, Espinosa C, et al. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. Am J Surg 1991;162:432-7.
8. Uren RF, Howman-Giles RB, Shaw HM, et al. Lymphoscintigraphy in high risk melanoma of the trunk predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med 1993;34:1435-40.
9. Uren RF, Howman-Giles R, Thompson JF, et al. Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma. Melanoma Res 1994;4:395-9.
10. Alex JC, Weaver DL, Fairbank JT, et al. Gamma-probe guided lymph node localization in malignant melanoma. Surg Oncol 1993; 2:303-8.
11. Essner R, Foshag L, Morton D. Intraoperative radiolymphoscintigraphy : A useful adjunct to intraoperative lymphatic mapping and selective lymphadenectomy in patients with clinical stage I melanoma. Proceedings of 47th Cancer Symposium, The Society of Surgical Oncology, March 1994, Houston, TX.
12. Van der Veen H, Hoekstra OS, Paul MA, et al. Gamma probe guided sentinel node biopsy to select patients with melanoma for lymphoscintigraphy. Br J Surg 1994;81:1769-70.
13. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996;223:217-24.
14. Thompson JF, McCarthy WH, Bosch CMJ, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995;5:255-60.
15. Kirkwood JM, Strawderman MH, Ernstoff MS, et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996;14:7-17.
16. Glass LF, Fenske NA, Messina JL, et al. The role of selective lymphadenectomy in the management of patients with malignant melanoma. Dermatol Surg 1995;21:979-83.